Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements

specific

A high-grade B-cell lymphoma with MYC and BCL2 or BCL6 rearrangements that is resistant to treatment.

Centers

Active Trials

—

Cancer Funding

Top Centers for Refractory High Grade B-Cell Lymphoma With MYC and BCL2 or BCL6 Rearrangements(25)

Ranked by research excellence score (trials · grants · publications). Methodology →

#	Center	Research Tier	Active Trials	Cancer Funding	Score
1	The Ohio State University Comprehensive Cancer Center - James Cancer Hospital & Solove Research InstituteColumbus, OH NCI Comprehensive High-Volume Research Center	High-Volume Research Center	3	—	73.6
2	Siteman Cancer CenterSt. Louis, MO NCI Comprehensive Active Research Program	Active Research Program	2	—	68.2
3	The University of Chicago Medicine Comprehensive Cancer CenterChicago, IL NCI Comprehensive Active Research Program	Active Research Program	2	—	68.2
4	The University of Arizona Cancer CenterTucson, AZ NCI Comprehensive Active Research Program	Active Research Program	2	—	68.2
5	University of Illinois Cancer CenterChicago, IL Active Research Program	Active Research Program	2	—	68.2
6	Cancer Center at IllinoisUrbana, IL Active Research Program	Active Research Program	2	—	68.2
7	Mayo Clinic Comprehensive Cancer CenterRochester, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
8	Yale Cancer Center Yale School of MedicineNew Haven, CT NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
9	Simmons Comprehensive Cancer Center UT Southwestern Medical CenterDallas, TX NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
10	Laura and Isaac Perlmutter Cancer Center at NYU Langone HealthNew York, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
11	Masonic Cancer CenterMinneapolis, MN NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
12	Moffitt Cancer CenterTampa, FL NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
13	Roswell Park Comprehensive Cancer CenterBuffalo, NY NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
14	University of Virginia Cancer CenterCharlottesville, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
15	Medical College of Wisconsin Cancer CenterMilwaukee, WI Active Research Program	Active Research Program	1	—	47.5
16	Cedars-Sinai CancerLos Angeles, CA Active Research Program	Active Research Program	1	—	47.5
17	VCU Massey Comprehensive Cancer CenterRichmond, VA NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
18	Fred & Pamela Buffett Cancer CenterOmaha, NE NCI Clinical Active Research Program	Active Research Program	1	—	47.5
19	The University of Kansas Cancer CenterKansas City, KS NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
20	Dartmouth Cancer CenterLebanon, NH NCI Comprehensive Active Research Program	Active Research Program	1	—	47.5
21	University of Cincinnati Cancer CenterCincinnati, OH Active Research Program	Active Research Program	1	—	47.5
22	Mayo Clinic Comprehensive Cancer Center, FloridaJacksonville, FL Active Research Program	Active Research Program	1	—	47.5
23	Mayo Clinic Comprehensive Cancer Center, ArizonaScottsdale, AZ Active Research Program	Active Research Program	1	—	47.5
24	The University of Vermont Cancer CenterBurlington, VT Active Research Program	Active Research Program	1	—	47.5
25	Rutgers Cancer InstituteNew Brunswick, NJ NCI Comprehensive		—	—	30.4

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →